Skip to main content
Clinical Trials/NCT00449826
NCT00449826
Completed
Not Applicable

Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)

Ottawa Heart Institute Research Corporation1 site in 1 country107 target enrollmentSeptember 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Coronary Syndrome
Sponsor
Ottawa Heart Institute Research Corporation
Enrollment
107
Locations
1
Primary Endpoint
Operating Characteristics of CTA
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this project is to examine the effectiveness of computed tomographic angiography (CTA) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). People who are hospitalized with this situation often require an angiogram to assess the heart and its arteries.

Recent advancements in technology have enabled CTA to clearly define coronary artery anatomy with great accuracy and to guide treatment strategies in select patient populations. We are investigating that CTA may be used, as an alternative to conventional angiograms, for the risk stratification of patients with high risk NSTE-ACS.

Patients eligible for the study will be high risk NSTE-ACS and awaiting an angiogram. Enrolled patients will undergo CTA prior to the angiogram. With each CTA the patient will be injected with a small dose of an X-ray dye and will be asked to lie still on the "scanning bed" for a period of 5-10 minutes.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
December 2010
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Benjamin Chow

Dr Benjamin Chow

Ottawa Heart Institute Research Corporation

Eligibility Criteria

Inclusion Criteria

  • High risk ACS
  • Angina \[accelerating pattern or prolonged episode (\> 20 minutes) or recurrent episode at rest or with minimal effort within preceding 24 hours\]; and (13)
  • Elevated Troponin - T (≥0.1 ug/L) or ECG changes consistent with ischemia \[ST depression ≥ 0.1 mV, transient ST segment elevation ≥ 0.1 mV (\< 20 minutes)\]) (11;13)
  • Planned conventional invasive coronary angiography

Exclusion Criteria

  • Age \< 18 years or lack of consent
  • Renal Insufficiency (GFR \< 60 ml/min)
  • Allergy to contrast agent
  • Refractory angina requiring urgent/emergent coronary angiography (as per treating physician)
  • Contraindication to radiation exposure (e.g. pregnancy)
  • Uncontrolled HR
  • Previous CABG or PCI/Stent
  • Atrial fibrillation, frequent atrial or ventricular ectopy (\> 1 / minute)
  • Unable to perform 20 second breath-hold

Outcomes

Primary Outcomes

Operating Characteristics of CTA

Time Frame: 1 month

Secondary Outcomes

  • To compare the accuracy of CTA to CICA in predicting the mode of revascularization (PCI versus CABG) in NSTE-ACS patients.(1 month)
  • To determine the number of "avoidable" CICA (i.e. those accurately designated to medical therapy or surgery with CTA).(1 month)

Study Sites (1)

Loading locations...

Similar Trials